Author Archives: JAIDS

High MIP-1β Levels in Plasma Predict Long-Term Immunological Nonresponse to Suppressive…

Background: HIV-infected patients who fail to reconstitute their CD4 T-cell counts during suppressive antiretroviral therapy (ART) have increased risk of both AIDS-related and non–AIDS-related morbidity and mortality.

Posted in Journal Watch | Comments closed

Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis…

Background: Preexposure prophylaxis (PrEP) for HIV prevention is a novel biomedical prevention method.

Posted in Journal Watch | Comments closed

Substance Use and HIV Among Female Sex Workers and Female Prisoners: Risk Environments and…

No abstract available

Posted in Journal Watch | Comments closed

Nationwide Study of Cancer in HIV-Infected Taiwanese Children in 1998–2009

No abstract available

Posted in Journal Watch | Comments closed

CMV Retinitis Diagnosis by Non-ophthalmologists: Learning Curve Over a 4-Day Training Workshop

No abstract available

Posted in Journal Watch | Comments closed

Implementation and Operational Research: High Loss to Follow-up Among Children on Pre-ART Care…

Background: Information on the follow-up of HIV-infected children enrolled into preantiretroviral therapy (Pre-ART) care under routine program settings is limited in India.

Posted in Journal Watch | Comments closed

Implementation and Operational Research: Effect of Universal Access to Antiretroviral Therapy…

Introduction: Universal coverage of highly active antiretroviral therapy (HAART) for HIV/AIDS in Mexico was achieved in a staggered fashion.

Posted in Journal Watch | Comments closed

Implementation and Operational Research: Maternal Combination Antiretroviral Therapy Is…

Background: Programs to prevent mother-to-child HIV transmission are plagued by loss to follow-up (LTFU) of HIV-exposed infants.

Posted in Journal Watch | Comments closed

Impact of Availability and Use of ART/PMTCT Services on Fertility Desires of Previously…

Objective: To assess fertility desires by availability and use of antiretroviral therapy and prevention of mother-to-child transmission (ART/PMTCT) services in Rakai, Uganda.

Posted in Journal Watch | Comments closed

Optima: A Model for HIV Epidemic Analysis, Program Prioritization, and Resource Optimization

Abstract: Optima is a software package for modeling HIV epidemics and interventions that we developed to address practical policy and program problems encountered by funders, governments, health planners, and program implementers.

Posted in Journal Watch | Comments closed

Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial…

Background: Evidence of gender differences in antiretroviral treatment (ART) outcomes in sub-Saharan Africa is conflicting.

Posted in Journal Watch | Comments closed

Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: …

Background: HIV-infected individuals with a history of transmission through injection drug use (IDU) have poorer survival than other risk groups.

Posted in Journal Watch | Comments closed

Critical Review: Building on the HIV Cascade: A Complementary “HIV States and…

Abstract: The HIV cascade—often referred to as “the HIV continuum”—provides a valuable framework for population-level representations of engagement with the HIV healthcare system.

Posted in Journal Watch | Comments closed

Implementation and Operational Research: Effects of CD4 Monitoring Frequency on Clinical End…

Background: Current treatment guidelines for HIV infection recommend routine CD4+ lymphocyte (CD4) count monitoring in patients with viral suppression.

Posted in Journal Watch | Comments closed